CellDrop Biosciences
PrivateLast Round
Grant
Oct 27, 2023
Total Funding Raised
$1.73M
Company Overview
CellDrop Biosciences operates in Healthcare & Life Sciences and is based in Laramie, Wyoming. Its latest recorded funding round was a Grant round in October 2023.
CellDrop Biosciences is a biotechnology company that develops hydrogel-based encapsulation platforms for scalable, allogeneic stem cell therapies and point-of-care diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CellDrop Biosciences Comparables
Compare CellDrop Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Equine Amnio Solutions, LLC | 86% | |
| eQcell Inc. | 82% | |
| EQGen Biomedical | 81% |
For institutional investors. Book with your work email.
CellDrop Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 27, 2023 | ||||
| Seed | Oct 26, 2023 | ||||
| Grant | Feb 3, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CellDrop Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Breakthrough 307 | Seed |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
Monthly visitors grew 418% MoM, reaching 803.
- May 4, 2025
Monthly visitors increased 705% MoM.
For institutional investors. Book with your work email.
CellDrop Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CellDrop Biosciences's valuation, stock price, and market status.
Is CellDrop Biosciences a public or private company?
CellDrop Biosciences is a private company.
What is the current stock price of CellDrop Biosciences?
CellDrop Biosciences is a private company, so its shares have no public market price. Caplight tracks CellDrop Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CellDrop Biosciences worth (valuation)?
Valuation information for CellDrop Biosciences is not publicly available.
Can I buy CellDrop Biosciences stock?
CellDrop Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CellDrop Biosciences's last funding round?
CellDrop Biosciences's most recent funding round was Grant on October 27, 2023.
Who are the main investors in CellDrop Biosciences?
Key investors in CellDrop Biosciences include Breakthrough 307, National Science Foundation.
Will CellDrop Biosciences IPO soon?
No public IPO plans have been announced for CellDrop Biosciences.
How can I track CellDrop Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in CellDrop Biosciences's shares on secondary markets.